Luke Alderwick
Has grant
Lecturer
United KingdomResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Luke Alderwick is a Lecturer at the University of Birmingham in the United Kingdom. His research areas include drug discovery and resistance mechanisms in Mycobacterium tuberculosis, focusing on innovative strategies to enhance immunogenicity and target non-canonical pathways. Notable recent articles explore topics such as the efficacy of azetidines against multidrug-resistant strains and the development of new inhibitors for Gram-negative bacteria.
Recent Grants
Grant: Close
Uncovering the mechanisms of ABC transporter glycoconjugate translocation in Mycobacterium tuberculosis and their roles in virulence.
Open Date: 2018-09-02
Close Date: 2021-09-01
Grant: Close
A new tool to support drug discovery: Native LESA mass spectrometry (NESA)
Open Date: 2018-03-31
Close Date: 2021-03-30
Grant: Close
Applying New Tools to Identify Inhibitors of Antimicrobial Resistance Plasmid Transmission or Stability in Gram Negative Bacteria
Open Date: 2016-03-21
Close Date: 2018-03-20
Grant: Close
The Mycobacterium tuberculosis Cell Envelope: unravelling complex cell wall assembly and the identification of potential new drug targets
Open Date: 2013-05-31
Close Date: 2018-11-30
Grant: Close
Team CanUK: Novel antibacterial targets, assays, probes and opportunities in bacterial cell wall biogenesis
Open Date: 2012-01-01
Close Date: 2015-12-31
Articles (9)
Year:
2024
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Collaborators (6)
Akina Yoshizawa
Assistant professor
Kyushu University
Liam Cox
University of Birmingham
Rian L. Griffiths
University of Nottingham
Moray Campbell
Assoc Prof
Ohio State University
Martin Read
University of Birmingham
Jamie Webster
University of Birmingham
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.